Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00881452 · ClinicalTrials.gov registry record · Phase 3

A Trial of CM-AT in Children With Autism

A Phase 3 study of Autism, sponsored by Curemark.

Completed
Registry status
Phase 3
Development phase
182
Enrollment target
19
Study locations

NCT00881452 is a Phase 3 study of Autism that has completed, run by Curemark. The registered enrollment target is 182 participants, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target. The trial reports 19 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00881452, a Phase 3 study of Autism, has completed, sponsored by Curemark.

COMPLETED
Registry status
Phase 3
Development phase
182 participants
Enrollment target
19
Study locations

Study Summary

The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism.

Conditions Studied

Autism

Interventions

  • DRUG Placebo
  • DRUG CM-AT

Study Locations (19)

California

  • University of California, Davis, M.I.N.D. Institute - Sacramento
  • University of California, San Francisco - San Francisco
  • Neuropsychiatric Research Center of Orange County - Santa Ana

Pennsylvania

  • Hershey Medical Center - Hershey
  • Drexel University - Philadelphia
  • University of Pittsburgh - Pittsburgh

Arizona

  • Southwest Autism Research and Resource Center - Phoenix

Florida

  • Lake Mary Pediatrics - Orange City

Georgia

  • Institute for Behavioral Medicine - Smyrna

Illinois

  • Alexian Brothers Center for Psychiatric Research - Hoffman Estates

Louisiana

  • Louisiana State University Health Science Center - Shreveport

New Jersey

  • Saint Peters University Hospital - New Brunswick

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2009-05
Est. Completion 2011-09
Phase Phase 3

Sponsor

Curemark

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00881452

The ClinicalTrials.gov registry entry for NCT00881452 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target. The listed sponsor is Curemark, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00881452 reports 19 study locations spanning 15 distinct geographic areas - top geographies include California, Pennsylvania, Arizona.

Frequently Asked Questions

What is clinical trial NCT00881452 about?

NCT00881452 is a clinical study titled "A Trial of CM-AT in Children With Autism". The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism.

What is the current status of trial NCT00881452?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2009-05. Estimated completion is 2011-09.

What conditions does trial NCT00881452 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT00881452?

The interventions under investigation include: Placebo (DRUG), CM-AT (DRUG).

Who is sponsoring clinical trial NCT00881452?

This trial is sponsored by Curemark, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00881452 being conducted?

This trial has 19 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.